Full Text View
Tabular View
No Study Results Posted
Related Studies
S-Frame CT Immobilization Masks For Patients Undergoing Radiation Therapy For Head and Neck Cancer
This study is currently recruiting participants.
Study NCT00252473   Information provided by University Health Network, Toronto
First Received: November 9, 2005   Last Updated: February 10, 2006   History of Changes

November 9, 2005
February 10, 2006
January 2005
 
Measurement of the accuracy of MedTec S-frame head and neck immobilization system (isocentre set-up accuracy, patient movement margins and movement of the normal tissue critical structures and planning target volumes)
Measurement of the accuracy of MedTec S-frame head and neck immobilization system.(Isocentre setup accuracy, patient movement margins and movement of the normal tissue critical structures and planning target volumes)
Complete list of historical versions of study NCT00252473 on ClinicalTrials.gov Archive Site
 
 
 
S-Frame CT Immobilization Masks For Patients Undergoing Radiation Therapy For Head and Neck Cancer
Evaluation of Setup Accuracy in Med Tec S-Frame Immobilization Masks For Patients Undergoing Radiation Therapy For Head and Neck Cancer

Immobilization devices such as thermoplastic masks are used routinely in the radiation treatment of head and neck cancer patients. It is important to assess how well they function at preventing patient motion while the radiation treatment is being delivered. (i.e. isocentre set-up margins, patient motion with the mask). If these new thermoplastic masks such as MedTec S-frame allow less movement, then smaller margins are needed during radiation therapy which, in turn, would decrease side effects from the treatment.

 
Phase II
Interventional
Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Safety/Efficacy Study
Head and Neck Neoplasms
Device: MedTec S-frame Immobilization Masks
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
30
 
 

Inclusion Criteria:

  • Histological confirmation of mucosal malignancy in the head and neck (H&N) region
  • Undergoing radiotherapy (RT) with curative intent using a lateral parallel pair treatment with an anterior or anterior/posterior low neck filed technique using a MedTec S-frame mask
Both
18 Years and older
No
Contact: Andrew Bayley, MD 416-946-2919 andrew.bayley@rmp.uhn.on.ca
Canada
 
NCT00252473
 
UHN REB 02-0832-C
University Health Network, Toronto
Princess Margaret Hospital, Canada
Principal Investigator: Andrew Bayley, MD Princess Margaret Hospital, Canada
University Health Network, Toronto
October 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP